|
|
|
貝萊德世界健康科學基金A2
(歐元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 歐元 |
47.86 |
0.46 |
0.97% |
2020/01/17 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 9.02% |
8.89% |
14.80% |
37.28% |
41.27% |
16.53% |
-5.12% |
7.12% |
10.13% |
26.72% |
| 貝萊德世界健康科學基金A2(歐元)
基金資料
|
|
●以盡量提高總回報為目標。基金在全球將總資產至少70%投資於從事保健、製藥、 醫學科技及生物科技供應及開發業務公司之股權證券。
●投資經驗豐富的研究團隊。健康醫療研究團隊成立超過半世紀，擁有產業豐富的投資經驗與優異的投資績效。
●掌握健康醫療產業長期投資利機點--全球人口老化、 重大醫學科技突破，以及中國、印度、東歐等快速成長新興市場生活水準提高。
●同時囊括醫療產業中生技、製藥、醫療保險服務與設備4大領域，兼顧防禦與成長。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/01/17 |
47.86 |
0.97% |
2020/01/03 |
46.13 |
-0.26% |
| 2020/01/16 |
47.40 |
0.36% |
2020/01/02 |
46.25 |
0.54% |
| 2020/01/15 |
47.23 |
1.55% |
2019/12/31 |
46.00 |
-0.50% |
| 2020/01/14 |
46.51 |
-0.64% |
2019/12/30 |
46.23 |
-0.56% |
| 2020/01/13 |
46.81 |
-0.76% |
2019/12/27 |
46.49 |
-0.41% |
| 2020/01/10 |
47.17 |
0.55% |
2019/12/23 |
46.68 |
0.24% |
| 2020/01/09 |
46.91 |
0.82% |
2019/12/20 |
46.57 |
0.91% |
| 2020/01/08 |
46.53 |
0.82% |
2019/12/19 |
46.15 |
0.04% |
| 2020/01/07 |
46.15 |
0.44% |
2019/12/18 |
46.13 |
0.52% |
| 2020/01/06 |
45.95 |
-0.39% |
2019/12/17 |
45.89 |
0.22% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
0.97% |
1.46% |
4.29% |
14.74% |
16.08% |
27.69% |
4.04% |
| NBI生技指數 |
-0.35% |
1.08% |
0.72% |
18.17% |
15.27% |
10.84% |
1.07% |
| 費城藥物指數 |
% |
% |
-100.30% |
-100.30% |
-100.30% |
-100.30% |
-100.30% |
| AMEX生技指數 |
-0.74% |
-0.47% |
0.58% |
20.40% |
10.38% |
6.85% |
2.15% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
1.37% |
3.53% |
13.93% |
14.86% |
19.69% |
2.32% |
| MSCI 製藥指數 (price) |
0.00% |
1.78% |
4.01% |
13.06% |
15.56% |
18.10% |
2.30% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.15% |
0.66% |
16.65% |
20.85% |
9.06% |
1.28% |
|
0.33% |
1.76% |
4.24% |
12.87% |
13.05% |
17.69% |
2.94% |
|
0.32% |
1.74% |
4.14% |
12.57% |
12.47% |
16.52% |
2.88% |
|
0.88% |
0.42% |
1.84% |
22.37% |
17.42% |
17.28% |
1.46% |
|
0.54% |
0.46% |
0.46% |
17.16% |
9.35% |
7.82% |
0.95% |
|
0.62% |
1.47% |
3.83% |
14.53% |
14.87% |
24.51% |
2.96% |
|
0.34% |
2.02% |
4.27% |
16.27% |
13.71% |
19.31% |
2.92% |
|
0.42% |
2.18% |
2.87% |
9.20% |
5.91% |
13.85% |
2.68% |
|
0.37% |
2.38% |
3.73% |
11.80% |
9.82% |
17.16% |
3.19% |
|
-0.33% |
1.89% |
-0.79% |
6.83% |
28.51% |
44.91% |
-0.30% |
|
0.99% |
1.28% |
4.36% |
13.61% |
14.57% |
27.24% |
3.90% |
|
-0.31% |
0.73% |
0.98% |
23.02% |
13.75% |
19.30% |
1.56% |
|
-0.29% |
0.69% |
0.87% |
22.60% |
13.01% |
17.79% |
1.49% |
|
0.50% |
0.77% |
3.26% |
19.28% |
15.97% |
26.46% |
1.60% |
|
-0.10% |
1.19% |
2.94% |
17.73% |
12.95% |
19.59% |
1.21% |
|
-0.12% |
1.17% |
2.86% |
17.40% |
12.38% |
18.40% |
1.14% |
|
-0.11% |
1.14% |
2.66% |
16.89% |
11.30% |
15.79% |
1.08% |
|
-0.12% |
1.14% |
2.72% |
17.11% |
11.72% |
16.67% |
1.11% |
|
-0.11% |
1.18% |
3.00% |
17.92% |
13.36% |
20.49% |
1.22% |
|
-0.11% |
0.77% |
0.94% |
12.11% |
10.22% |
10.82% |
1.27% |
|
0.31% |
0.85% |
0.63% |
20.09% |
10.59% |
12.28% |
1.96% |
|
0.68% |
0.89% |
1.35% |
21.17% |
13.38% |
18.85% |
3.16% |
|
0.31% |
0.90% |
0.89% |
20.91% |
12.18% |
15.86% |
2.07% |
|
0.45% |
0.97% |
2.94% |
10.85% |
7.94% |
13.57% |
1.39% |
|
0.82% |
1.01% |
3.69% |
11.84% |
10.68% |
20.21% |
2.58% |
|
0.45% |
1.02% |
3.22% |
11.60% |
9.51% |
17.19% |
1.50% |
|
0.11% |
0.55% |
0.15% |
22.04% |
15.21% |
13.94% |
1.72% |
|
0.53% |
1.32% |
3.05% |
15.02% |
14.34% |
25.11% |
2.27% |
|
0.35% |
2.89% |
3.45% |
18.26% |
17.04% |
23.11% |
3.45% |
|
0.24% |
2.92% |
3.93% |
19.83% |
18.16% |
24.05% |
3.17% |
| 基金平均績效 |
0.30% |
1.31% |
2.56% |
16.25% |
13.31% |
19.45% |
2.09% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
